BrightHouse Financial (BHF) Q3 2024: $2.4B Buyback Reduces Shares by 50% as Capital Actions Accelerate
BrightHouse Financial’s third quarter was defined by a decisive shift in capital management, with a pending reinsurance deal and a multi-year $2.4 billion buyback reducing share count by more than half since 2017. Capital strain from new business and hedging complexity remain core challenges, but management’s actions signal a near-term inflection in risk-based capital and cash flow dynamics. Investors should watch execution on hedging simplification and reinsurance closure for confirmation of a more stable capital base going into 2025.
Summary
- Capital Unlock in Focus: Pending reinsurance and hedging changes target a return to target RBC range.
- Expense Discipline Maintained: Corporate expenses down year-over-year despite capital headwinds.
- Shareholder Returns Accelerate: Buybacks continue, with $2.4 billion repurchased since 2018.
Business Overview
BrightHouse Financial is a U.S.-based life insurance and annuity provider, generating revenue primarily through the sale and management of annuity products (including variable, fixed, and registered index-linked annuities, or RILAs) and life insurance policies. Its core segments include the annuity business—anchored by the flagship Shield suite—life insurance, and a runoff segment managing legacy closed blocks. The company leverages third-party distribution channels and maintains a focus on low-cost operations to drive growth and profitability.
Performance Analysis
BHF’s third quarter reflected both the strengths and the complexity of its capital structure. Statutory total adjusted capital (TAC) rose to $5.7 billion, up $300 million sequentially, primarily from hedging program simplification. However, the estimated combined risk-based capital (RBC) ratio remained below the 400%–450% target, at 365%–385%, due to ongoing new business strain and a modest statutory loss. The company expects this to rebound to the low end of the target range pro forma for a pending reinsurance transaction.
Sales momentum was evident: year-to-date annuity sales reached $7.8 billion, with Shield annuity sales at a record $5.8 billion, up 15% over 2023. Life insurance sales also grew 19% year-over-year. Despite a dip in fixed deferred annuity sales earlier in the year, volumes rebounded in Q3 following a reinsurer transition. Expense discipline was notable, with corporate expenses down 5% year-to-date and full-year costs expected to remain below 2023 levels.
- Hedging Program Complexity: The shift to standalone hedging for new Shield business aims to reduce capital strain and simplify risk management.
- Reinsurance as Capital Lever: Final-stage negotiations on a legacy block reinsurance deal are expected to restore RBC to target range.
- Buybacks Remain Aggressive: $64 million repurchased in Q3, $2.4 billion since 2018, reducing shares outstanding by over 50%.
Adjusted earnings excluding notable items fell sequentially, primarily due to lower alternative investment returns and normalized statutory losses, but underwriting margins remained broadly in line with expectations outside of typical quarterly volatility.
Executive Commentary
"We continued to make progress on our strategic initiatives designed to improve capital efficiency, unlock capital, and return our combined risk-based capital, or RBC, ratio to our target range of 400% to 450% in normal market conditions."
Eric Stagerwald, President and Chief Executive Officer
"The key change we anticipate in the fourth quarter and beyond is less strain from new business...the biggest financial benefit that we see is less strain. And I would also add the other significant benefit that is difficult to quantify but I think is important over time is simplification of our hedging strategy."
Ed Sehar, Chief Financial Officer
Strategic Positioning
1. Capital Efficiency and RBC Restoration
Management is prioritizing actions to unlock capital and restore the RBC ratio to its target range. The pending reinsurance deal covering a legacy block of fixed and payout annuities is positioned as a near-term catalyst, with pro forma estimates showing a return to the lower end of the 400%–450% range. This is critical for regulatory comfort and long-term growth capacity.
2. Hedging Simplification and Risk Segmentation
The transition to hedging Shield new business on a standalone basis is a structural pivot, designed to reduce new business strain and operational complexity. The legacy block is now treated as a closed block, with a separate hedging approach under development for 2025, aiming for greater predictability and capital stability.
3. Product and Distribution Strength
BrightHouse’s Shield annuity suite continues to drive market share in the RILA segment, with record sales and sustained growth. The company’s broad third-party distribution network and complementary product offerings support resilience in both annuity and life segments.
4. Expense Management and Operating Leverage
Operational discipline remains a core pillar, with year-to-date corporate expenses down 5% and a full-year outlook for costs to remain below 2023. This positions BHF as a low-cost producer, supporting margin stability in a competitive environment.
5. Shareholder Capital Return
Buybacks remain a central lever, with $2.4 billion repurchased since 2018 and a robust $1.3 billion in holding company liquid assets. This aggressive repurchase activity has reduced shares outstanding by more than 50% since 2017, amplifying per-share value creation even amid capital headwinds.
Key Considerations
This quarter’s results underscore a company in transition, balancing capital strain from new business with decisive actions to unlock capital and simplify risk.
Key Considerations:
- Reinsurance Execution Timing: Closure of the legacy block deal is pivotal for near-term capital relief and regulatory optics.
- Hedging Program Overhaul: Full impact of standalone hedging for Shield new business will be realized in Q4 and beyond, with legacy block strategy still in development.
- Sales Sustainability: Record Shield sales highlight distribution strength, but maintaining this pace as capital constraints ease will be critical.
- Expense Control: Continued cost discipline is necessary to offset margin pressure from lower investment yields and new business strain.
- Shareholder Returns: Robust capital at the holding company supports ongoing buybacks, but future pace will depend on regulatory and capital position post-reinsurance.
Risks
Execution risk remains high, particularly around closing the reinsurance transaction and finalizing the legacy block hedging strategy. Capital strain from new business has been higher than anticipated, and any delays or setbacks in simplification initiatives could prolong sub-target RBC ratios. Further, competitive pressure in the annuity market and volatility in alternative investment returns may impact earnings consistency and capital generation. Regulatory scrutiny of capital adequacy is an ongoing backdrop, and any adverse market developments could test the effectiveness of revised risk management frameworks.
Forward Outlook
For Q4 2024, BrightHouse expects:
- Pro forma RBC ratio to return to the lower end of the 400%–450% target range, subject to reinsurance deal closure.
- Corporate expense increase due to seasonality, but full-year expenses to remain below 2023.
For full-year 2024, management maintained guidance for:
- Corporate expenses below prior-year levels.
Management emphasized that capital strain from new business will be substantially reduced, and simplification of the hedging strategy should enhance capital predictability. Continued robust Shield sales and disciplined expense management are expected to support earnings, while the timing and impact of additional reinsurance and hedging changes will shape the 2025 outlook.
Takeaways
BrightHouse is at a capital management inflection, with aggressive buybacks, a pending reinsurance catalyst, and a simplified hedging approach poised to stabilize risk metrics.
- Capital Actions Dominate: The pending reinsurance deal and hedging overhaul are the primary levers to restore regulatory capital and unlock future cash flow.
- Operational Execution Holds: Record Shield sales and expense discipline provide operational ballast, but capital and risk management execution will define near-term valuation.
- 2025 Watchpoint: Investors should monitor the rollout of the legacy block hedging strategy and additional reinsurance or capital optimization actions for further upside or risk.
Conclusion
BrightHouse Financial’s Q3 2024 was defined by capital maneuvering, with a pending reinsurance transaction and hedging simplification aiming to restore regulatory ratios and support growth. Operational execution remains solid, but the coming quarters will test management’s ability to deliver on capital and risk management promises.
Industry Read-Through
BrightHouse’s experience highlights the increasing complexity and capital intensity of the annuity and life insurance sector, especially for providers with large legacy blocks and evolving hedging needs. Peers may face similar pressures to simplify risk management frameworks and pursue capital unlocking transactions, particularly as regulatory scrutiny on RBC ratios intensifies. The aggressive use of buybacks as a capital return lever, funded by robust holding company liquidity, could become a more common playbook for insurers with constrained organic growth. Reinsurance remains a critical tool for capital relief, and the market will be watching for broader adoption of similar strategies across the sector as interest rate and investment volatility persist.